NorthWest Biotherapeutics Inc (NWBO)

[trocprofit]

The quote in that article is specific!
"DCVax has recently been approved by the US Food and Drug Administration (FDA) as an immunotherapeutic agent; its promising clinical outcome has been reported in phase 3 trials for treatment of glioblastoma multiforme. Provenge (sipuleucel-T), the other FDA-approved DC vaccine, has been adopted in treatment of progressive prostate cancer resulting in prolonged survival."